Wells Fargo Upgrades Humana (HUM) to Outperform; Compelling Valuation
Tweet Send to a Friend
Get Alerts HUM Hot Sheet
Price: $78.93 -1.14%
Rating Summary:
9 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
9 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade HUM Now!
Wells Fargo upgraded Humana (NYSE: HUM) from Market Perform to Outperform with a price target range $87-96.
Analyst, Peter Costa, said, "We continue to view Medicare Advantage as a key tool to manage seniors' health care costs and help control Federal spending on Medicare. We view Humana as well positioned within Medicare Advantage and expect it to grow more rapidly than most other health insurers, not just from increasing its market share, but also due to the growing senior demographic and relative under-penetration of managed care in the senior population. Furthermore, we believe Humana has less risk associated with the upcoming Supreme Court ruling on health reform, since its key business is Medicare Advantage."
For an analyst ratings summary and ratings history on Humana click here. For more ratings news on Humana click here.
Shares of Humana closed at $75.75 yesterday, with a 52 week range of $65.20-$96.46.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Peter Costa, said, "We continue to view Medicare Advantage as a key tool to manage seniors' health care costs and help control Federal spending on Medicare. We view Humana as well positioned within Medicare Advantage and expect it to grow more rapidly than most other health insurers, not just from increasing its market share, but also due to the growing senior demographic and relative under-penetration of managed care in the senior population. Furthermore, we believe Humana has less risk associated with the upcoming Supreme Court ruling on health reform, since its key business is Medicare Advantage."
For an analyst ratings summary and ratings history on Humana click here. For more ratings news on Humana click here.
Shares of Humana closed at $75.75 yesterday, with a 52 week range of $65.20-$96.46.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: A.G. Lafley Gives Procter & Gamble (PG) Investors 'New Hope', UBS Upgrades to Buy
- Jefferies Upgrades DDR Corp. (DDR) to Buy
- Piper Jaffray Upgrades Gordmans Stores (GMAN) to Overweight
Create E-mail Alert Related Categories
UpgradesRelated Entities
Wells Fargo
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
